D59.12
D59.12: Cold autoimmune hemolytic anemia
Billable / specific codeICD-10-CM
D59.12 is a billable, specific ICD-10-CM code for cold autoimmune hemolytic anemia. It is valid for submission on a claim.
Check D59.12 with the rest of the claim: free scrubberInclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Chronic cold hemagglutinin disease
- Cold agglutinin disease
- Cold agglutinin hemoglobinuria
- Cold type (primary) (secondary) (symptomatic) autoimmune hemolytic anemia
- Cold type autoimmune hemolytic disease
Risk adjustment
D59.12 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 109 Acquired Hemolytic, Aplastic, and Sideroblastic Anemias1.144 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
D59.12 is named in 16 Medicare coverage policies: 16 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A55639Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions
- A56380Billing and Coding: Rituximab
- A56464Billing and Coding: Flow Cytometry
- A56718Billing and Coding: Intravenous Immunoglobulin (IVIG)
Alphabetic index entries that lead here
- Cold›agglutinin disease or hemoglobinuria(chronic)
- Cold›sensitivity, auto-immune
- Sensitive, sensitivity›cold, autoimmune
- Anemia›hemolytic›cold type(primary) (secondary) (symptomatic)
- Disease, diseased›cold›agglutinin or hemoglobinuria
- Disease, diseased›cold›hemagglutinin(chronic)
- Hemoglobinuria›cold›agglutinin
- Anemia›hemolytic›autoimmune›cold
- Disease, diseased›autoimmune NOS›hemolytic›cold type(primary) (secondary) (symptomatic)
- Disease, diseased›hemolytic›autoimmune›cold type(primary) (secondary) (symptomatic)
- Anemia›hemolytic›primary›autoimmune›cold type
- Anemia›hemolytic›secondary›autoimmune›cold type
Code history
Unchanged in every release from FY2024 to FY2027.